A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection.

about

A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection.

Item

http://www.wikidata.org/entity/Q36539414

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@ast

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@en

type

Item

label

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@ast

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@en

prefLabel

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@ast

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@en

P1476

A preliminary method developme ...... s with nanoLC-ESIMS detection.

@en

P2093

Joseph Caruso

http://www.w3.org/2001/XMLSchema#string

Julio A Landero-Figueroa

http://www.w3.org/2001/XMLSchema#string

Opeolu Adeoye

http://www.w3.org/2001/XMLSchema#string

Phanichand Kodali

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry

Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke

Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2

Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.

Characterization of the low molecular weight human serum proteome.

Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

P2888

s00702-013-1018-9

P304

1441-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-013-1018-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23580158

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4739646

http://www.w3.org/2001/XMLSchema#string